<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Small intestinal bacterial overgrowth: Etiology and pathogenesis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Small intestinal bacterial overgrowth: Etiology and pathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Small intestinal bacterial overgrowth: Etiology and pathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ayesha Shah, MBBS, FRACP, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gerald Holtmann, MD, PhD, MBA, FRACP, FRCP, FAHMS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 23, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Small intestinal bacterial overgrowth (SIBO) is a condition in which colonic and oro-pharyngeal bacteria are seen in excess in the small intestine. When present, this overabundance of organisms can result in intestinal symptoms and, in extreme cases, malabsorption. Small intestinal dysbiosis is defined as changes in the composition, density, and function of the microbes in the intestine. SIBO is a type of small intestinal dysbiosis [<a href="#rid1">1</a>]. </p><p>This topic will review the etiology and pathogenesis of SIBO. The clinical manifestations, diagnosis, and treatment of SIBO are discussed separately. (See  <a class="medical medical_review" href="/d/html/4776.html" rel="external">"Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/4778.html" rel="external">"Small intestinal bacterial overgrowth: Management"</a>.)</p><p class="headingAnchor" id="H1800793147"><span class="h1">INTESTINAL MICROBIOME</span></p><p class="headingAnchor" id="H3535900952"><span class="h2">Overview</span><span class="headingEndMark"> — </span>The stomach and proximal small bowel normally contain relatively few bacteria due to the acidic environment, high concentration of bile acid and digestive enzymes, and the effects of peristalsis. Other protective factors also contribute to this, such as the integrity of the mucosal lining of the intestines and the protective layer of mucus, the beneficial effects of certain bacteria like lactobacilli, and the mechanical and physiological properties of the ileocecal valve (ICV) along with the local and overall immune responses [<a href="#rid1">1</a>]. The number of bacterial cells in the mammalian gut varies, ranging from 10<sup>1</sup> to 10<sup>3</sup> bacteria colony forming units (CFU)/mL in the stomach and duodenum. The microorganisms found in the stomach most commonly include various gram-positive aerobes like streptococci, staphylococci, lactobacilli, and various fungi and facultative anaerobes, similar to the flora of the oropharynx [<a href="#rid2">2</a>]. Under normal conditions, the microflora of the proximal small bowel is similar to that of the stomach. Lactobacilli, enterococci, gram-positive aerobes, or facultative anaerobes predominate in concentrations of 10<sup>4</sup> organisms/mL in the mid to distal jejunum [<a href="#rid3">3</a>]. The concentration of coliforms rarely exceeds 10<sup>3</sup> organisms/mL [<a href="#rid4">4</a>]. <em>Bacteroides</em>, coliforms and other anaerobic bacteria, the predominant organisms in the colon, are rarely found in the proximal small bowel.</p><p>The microbiology of the terminal ileum represents an intermediary zone between the aerobic flora found in the stomach and proximal small intestine . In the distal ileum, gram-negative bacteria begin to outnumber gram-positive organisms. The concentration of organisms may be as high as 10<sup>9</sup>/mL and includes coliforms and anaerobic bacteria such as <em>Bacteroides</em>, <em>Bifidobacterium, Fusobacterium</em>, and <em>Clostridium</em>, which are found in substantial concentration. If the ileocecal valve is dysfunctional or surgically absent, the microbiology of the terminal ileum resembles that of the colon. (See  <a class="medical medical_review" href="/d/html/2556.html" rel="external">"Spatial organization of intestinal microbiota in health and disease", section on 'Stomach and duodenum'</a>.)</p><p>In the colon, the concentration of microorganisms may exceed 10<sup>12</sup>/mL; anaerobic bacteria outnumber aerobes by 1000-fold. The organisms are predominantly anaerobes such as <em>Bacteroides</em>, <em>Lactobacillus</em>, <em>Clostridium</em>, and bifidobacteria, although multiple species coexist. (See  <a class="medical medical_review" href="/d/html/2556.html" rel="external">"Spatial organization of intestinal microbiota in health and disease", section on 'Bacteria in the colon'</a>.)</p><p>Fungi, primarily Candida species, are present in the gastrointestinal tract of approximately 70 percent of healthy adult individuals [<a href="#rid5">5</a>]. Small intestinal fungal overgrowth (SIFO) has been associated with unexplained gastrointestinal symptoms, however, evidence to support eradication are lacking [<a href="#rid6">6</a>]. </p><p class="headingAnchor" id="H7"><span class="h2">Protective mechanisms against bacterial overgrowth</span><span class="headingEndMark"> — </span>Several host defense mechanisms prevent excessive colonization by bacteria:</p><p class="bulletIndent1"><span class="glyph">●</span>Gastric acid and bile (as a detergent) destroy many microorganisms in ingested food and prevent them from passing through the proximal digestive tract.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Digestion by proteolytic enzymes helps destroy bacteria in the small intestine.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An intact ileocecal valve and the antegrade motility pattern of the ileum inhibit retrograde translocation of bacteria from the colon to the small bowel [<a href="#rid7">7,8</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The largest fraction of immunoglobulins secreted in the human body is the secretory IgA originating in the gastrointestinal tract, which aids in preventing bacterial proliferation [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/d/html/89914.html" rel="external">"Structure and biologic functions of IgA"</a>.)</p><p></p><p class="headingAnchor" id="H8"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The exact prevalence of SIBO is unclear. In the absence of population-based studies, the information about the prevalence of SIBO is derived predominantly from retrospective studies in symptomatic or at-risk cohorts. SIBO is highly prevalent in various gastrointestinal disorders, particularly disorders of gut-brain interactions such as irritable bowel syndrome and functional dyspepsia, chronic pancreatitis, chronic liver disease, celiac disease, inflammatory bowel disease, and intestinal failure [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/d/html/2629.html" rel="external">"Pathophysiology of irritable bowel syndrome", section on 'Bacterial overgrowth'</a> and  <a class="medical medical_review" href="/d/html/5649.html" rel="external">"Chronic pancreatitis: Clinical manifestations and diagnosis in adults"</a>.)</p><p class="headingAnchor" id="H4044693181"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Disorders that affect one or more of the protective mechanisms can lead to SIBO. In general, the etiology of SIBO can be divided into categorical causes. </p><p class="headingAnchor" id="H5319243"><span class="h2">Functional and motility disorders</span><span class="headingEndMark"> — </span>The classic mechanism for cleansing the small bowel of debris and preventing SIBO is the propulsive motility manifesting during the interdigestive phase as the migrating motor complex (MMC; also addressed as interdigestive phase III activity) [<a href="#rid11">11</a>]. A lack of interdigestive phase III activity is seen in irritable bowel syndrome, narcotic use, intestinal pseudo-obstruction, and diabetes. Small bowel motility may be affected in patients with acute or chronic radiation enteritis. More extreme motility disorders, such as scleroderma, can progress to include neuropathy and even myopathy of the gut, which further reduce flow, leading to SIBO [<a href="#rid12">12-16</a>]. (See  <a class="medical medical_review" href="/d/html/2631.html" rel="external">"Treatment of irritable bowel syndrome in adults", section on 'Antibiotics'</a> and  <a class="medical medical_review" href="/d/html/2629.html" rel="external">"Pathophysiology of irritable bowel syndrome", section on 'Bacterial overgrowth'</a>.) </p><p class="headingAnchor" id="H5319256"><span class="h2">Anatomic disorders</span><span class="headingEndMark"> — </span>Anatomic abnormalities can lead to SIBO by causing stasis. Anatomic disorders associated with SIBO include adhesions from previous surgery; strictures due to radiation, inflammatory bowel disease, or tumors of the small bowel; small intestinal diverticulosis; blind intestinal loops; reversed segments; and gastric bypass for the treatment of obesity [<a href="#rid17">17</a>]. </p><p class="headingAnchor" id="H5319268"><span class="h2">Immune disorders</span><span class="headingEndMark"> — </span>Combined variable immunodeficiency, IgA deficiency, and acquired immunodeficiency (eg, HIV) are associated with an increased risk of SIBO. Intestinal immunity is important in maintaining the correct microbial composition in the small intestine. Pathogenic bacteria may be able to dampen the local immune system, hence disrupting normal gastrointestinal function [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/d/html/99315.html" rel="external">"Gastrointestinal manifestations in primary immunodeficiency"</a>.)</p><p class="headingAnchor" id="H3164642087"><span class="h2">Gastric hypochlorhydria</span><span class="headingEndMark"> — </span>Hypochlorhydria, either from long-term use of a proton pump inhibitor (PPI) or autoimmune etiology (chronic atrophic gastritis), is an important co-factor in the development of SIBO. PPIs raise the pH levels in the stomach and result in hypochlorhydria, which has been hypothesized to alter the intraluminal environment to promote colonization by large intestinal flora in the small intestine. This occurs because the acidic environment in the stomach, which typically acts as a barrier against microbial infections, becomes weaker. While some studies have indicated a correlation between long-term PPI therapy and SIBO [<a href="#rid19">19</a>], others have been unable to support this finding [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H3981867032"><span class="h2">Systemic disorders</span><span class="headingEndMark"> — </span>There is increased prevalence of SIBO in gastrointestinal diseases like celiac disease, inflammatory bowel disease, chronic pancreatitis, intestinal failure, and disorders of gut-brain interactions including irritable bowel syndrome and functional dyspepsia. SIBO is also linked to various extraintestinal disorders like diabetes, acromegaly, hypothyroidism, myotonic muscular dystrophy, chronic liver disease, cystic fibrosis, scleroderma, and end-stage liver disease [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H978347923"><span class="h1">PATHOPHYSIOLOGY</span></p><p class="headingAnchor" id="H3980473805"><span class="h2">Bacterial overgrowth</span><span class="headingEndMark"> — </span>SIBO is usually associated with abnormally high bacterial populations in the small intestine. However, the presence of excess numbers of bacteria in the small bowel does not identify whether or not the bacteria are doing any harm, a point that is often misunderstood. Inflammation that occurs in patients with clinical manifestations of SIBO is likely due to invasive strains of bacteria, which result in a variety of epithelial changes [<a href="#rid18">18</a>]. Multiple organisms are typically present in varying numbers. A study utilizing culture and shotgun sequencing suggests that two main organisms are responsible for SIBO and include <em>Escherichia coli</em> and <em>Klebsiella spp </em>[<a href="#rid22">22</a>]. Other common Gram-negative flora are <em>Proteus, Acinetobacter, Enterobacter, Citrobacter, Neisseria, Bacteroides,</em> and <em>Clostridia,</em> while predominant isolated Gram-positive flora may include <em>Streptococcus, Staphylococcus, Enterococcus, Micrococcus, Lactobacillus, Corynebacterium, Fusobacterium</em>, and <em>Peptostreptococcus</em>. There may be a mix of Gram-positive and Gram-negative populations, as well as aerobic and anaerobic bacteria [<a href="#rid23">23,24</a>].</p><p>Facultative anaerobes may injure the intestinal surface by direct adherence and production of enterotoxins. Aerobic bacteria produce enzymes and metabolic products that are also capable of inducing epithelial cell injury [<a href="#rid25">25</a>]. Clinically significant SIBO is diagnosed when bacterial counts exceed 10<sup>3</sup> organisms/mL in a patient with typical clinical features (eg, abdominal pain, bloating, diarrhea) [<a href="#rid4">4,26</a>]. (See  <a class="medical medical_review" href="/d/html/4776.html" rel="external">"Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis", section on 'Small bowl aspirate culture'</a>.)</p><p class="headingAnchor" id="H215092810"><span class="h2">Intestinal effects</span></p><p class="headingAnchor" id="H3028895455"><span class="h3">Motility and nutrient absorption</span><span class="headingEndMark"> — </span>Impaired absorption of nutrients in SIBO results from either maldigestion in the intestinal lumen, or from malabsorption at the level of the intestinal microvillus membrane due to enterocyte damage. However, it is notable that malabsorption is usually seen in only severe cases of SIBO, usually due to iatrogenic SIBO such as blind loop syndrome [<a href="#rid26">26</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fat malabsorption</strong> – Fat malabsorption can lead to weight loss, steatorrhea, and deficiencies of fat-soluble vitamins A, D, and K. Fat malabsorption results from bacterial deconjugation of bile acids and the toxic effect of free bile acids on the intestinal mucosa [<a href="#rid27">27,28</a>]. At physiologic pH, bile acids are fully ionized, preventing their absorption in the proximal small intestine and permitting sufficient concentrations for solubilization of dietary fat. However, deconjugated bile salts resulting from SIBO are reabsorbed by the jejunum, which may lead to insufficient concentrations for normal fat absorption. Bacterial deconjugation also leads to the production of lithocholic acid, which may be toxic to intestinal epithelium, resulting in impaired absorption of fat and other nutrients. Hydroxylated fatty acids (and free bile acids) also stimulate the secretion of water and electrolytes, leading to diarrhea. (See  <a class="medical medical_review" href="/d/html/4776.html" rel="external">"Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Carbohydrate malabsorption </strong>– Intraluminal degradation of carbohydrates leads to the production of short-chain fatty acids (butyrate, propionate, acetate, lactate) as well as carbon dioxide, hydrogen, and methane, which may be associated with acidic stools, abdominal distension, and flatulence. In addition, enterocyte damage from the effect of bile acids or from the bacteria themselves may reduce enterocyte disaccharidase activity and the transport of monosaccharides [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Protein malabsorption </strong>– Protein malabsorption results from decreased mucosal uptake of amino acids, and the intraluminal degradation of protein precursors by bacteria [<a href="#rid30">30</a>]. SIBO may also result in a reversible form of protein-losing enteropathy [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/4769.html" rel="external">"Protein-losing gastroenteropathy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vitamin B12 malabsorption </strong>– Although enteric bacteria synthesize cobalamin, they also successfully compete with the host for its absorption. Only anaerobes are able to utilize vitamin B12 coupled to intrinsic factor, and their eradication is necessary to restore normal ileal absorption. Malabsorption of vitamin B12 may result in anemia and neurologic disturbances. (See  <a class="medical medical_review" href="/d/html/7153.html" rel="external">"Causes and pathophysiology of vitamin B12 and folate deficiencies"</a> and  <a class="medical medical_review" href="/d/html/7155.html" rel="external">"Clinical manifestations and diagnosis of vitamin B12 and folate deficiency"</a>.)</p><p></p><p class="bulletIndent1">Bacteria also synthesize <a class="drug drug_general" data-topicid="8475" href="/d/drug information/8475.html" rel="external">folic acid</a>. Unlike cobalamin, however, folic acid is released into the small bowel lumen, where it can be absorbed. Thus, patients with SIBO rarely have folate deficiency.</p><p></p><p>Bacterial overgrowth may also disturb small bowel motility, causing nausea, anorexia, and bloating [<a href="#rid32">32</a>]. </p><p class="headingAnchor" id="H679937947"><span class="h3">Morphology and histopathology</span><span class="headingEndMark"> — </span>The endoscopic appearance and histopathology of the small intestine and colon are normal in most patients with SIBO. Nonspecific changes in the small intestine and colon include mucosal edema, loss of normal vascular pattern, patchy erythema, friability, and, in rare cases, ulceration may be seen [<a href="#rid33">33-35</a>]. </p><p>Histopathological changes in patients with SIBO are also nonspecific and include villous blunting, cryptitis, intraepithelial lymphocytosis, and eosinophilia [<a href="#rid36">36</a>]. </p><p class="headingAnchor" id="H167069813"><span class="h2">Systemic effects</span><span class="headingEndMark"> — </span>Production of toxins and increased intestinal permeability in SIBO have been associated with systemic complications. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications of chronic liver disease</strong> – Cirrhosis is the common end-stage of chronic liver diseases of different etiology. Small intestinal dysbiosis and SIBO, with subsequent low grade mucosal immune activation and increased intestinal permeability, are now considered to play a critical role in the pathophysiology and progression of chronic liver disease.</p><p></p><p class="bulletIndent1">Microbial changes in the intestine, and in particular SIBO, may affect the gut barrier. Barrier dysfunction has been implicated in the pathogenesis of chronic liver disease and may facilitate translocation of gut bacteria. In advanced liver disease patients, bacterial translocation occurs. It leads to increased proinflammatory responses to bacterial products from the gut. These factors, combined with the patient's susceptibility, contribute to remote organ injury [<a href="#rid37">37-39</a>]. Examples of such injuries include acute-on-chronic liver failure, hepatorenal syndrome, hepatic encephalopathy, and spontaneous bacterial peritonitis (SBP).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>D-lactic acidosis</strong> – D-lactic acidosis is a rare neurologic syndrome in patients with SIBO associated with short bowel syndrome or a prior jejunoileal bypass. It is characterized by altered mental status ranging from confusion to coma, slurred speech, seizures, and ataxia resulting from bacterial fermentation of unabsorbed carbohydrates [<a href="#rid40">40,41</a>]. (See  <a class="medical medical_review" href="/d/html/2303.html" rel="external">"D-lactic acidosis", section on 'Pathogenesis'</a> and  <a class="medical medical_review" href="/d/html/4776.html" rel="external">"Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonalcoholic fatty liver disease</strong> – Intestinal microbes have been implicated as a potential source of hepatotoxic oxidative injury [<a href="#rid42">42-44</a>]. While some studies have suggested that the prevalence of SIBO may be higher in patients with nonalcoholic steatohepatitis as compared with healthy controls, breath tests were used to establish the diagnosis and total bacterial counts in the feces were not significantly different [<a href="#rid45">45</a>]. Further studies are needed to establish the role of SIBO in the pathogenesis of nonalcoholic fatty liver disease [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/d/html/3596.html" rel="external">"Pathogenesis of nonalcoholic fatty liver disease", section on 'Intestinal microbes'</a>.) </p><p></p><p class="headingAnchor" id="H2605676830"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/119548.html" rel="external">"Society guideline links: Small intestinal bacterial overgrowth"</a>.)</p><p class="headingAnchor" id="H1296615353"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Small intestinal bacterial overgrowth (SIBO) is a condition in which the small bowel is colonized by excessive aerobic and anaerobic microbes that are normally present in the colon. When present, this overabundance of organisms can result in unexplained gastrointestinal symptoms such as bloating, abdominal pain, constipation, and diarrhea and, in extreme cases, intestinal inflammation and malabsorption. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Host mechanisms protect against excessive small intestinal colonization by bacteria. These include the digestion by gastric acid, bile, and proteolytic enzymes; an intact ileocecal valve and antegrade motility pattern of the ileum that inhibit retrograde translocation of bacteria; and local and systemic immunity, which aids in preventing bacterial proliferation. (See <a class="local">'Protective mechanisms against bacterial overgrowth'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The exact prevalence of SIBO is unclear. However, SIBO has been linked to several gastrointestinal and extra-intestinal diseases. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>SIBO can occur in association with anatomical abnormalities (eg, diverticula, fistulas, surgical blind loop, ileocecal resections), motility disorders (eg, scleroderma, irritable bowel syndrome, functional dyspepsia), metabolic and systemic disorders (eg, diabetes mellitus, achlorhydria, chronic pancreatitis, cirrhosis), and immune disorders (eg, HIV). (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The nonspecific inflammation that occurs in patients with severe clinical manifestations of SIBO is likely due to more invasive strains of bacteria, which result in a variety of epithelial changes. Clinically significant SIBO is diagnosed when bacterial counts exceed 10<sup>3</sup> colony forming units of bacteria/mL in a patient with typical clinical features (eg, abdominal pain, bloating, diarrhea). (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Impaired absorption of nutrients in SIBO results from either maldigestion in the intestinal lumen, or malabsorption at the level of the intestinal microvillus membrane due to enterocyte damage. These deficiencies are seen in more extreme cases of SIBO, which rarely occur. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Carbohydrate malabsorption results from the intraluminal degradation of sugars by enteric bacteria. This leads to the production of short-chain fatty acids, carbon dioxide, hydrogen, and methane.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fat malabsorption results from bacterial deconjugation of bile acids and the toxic effect of free bile acids on the intestinal mucosa. Hydroxylated fatty acids and free bile acids stimulate the secretion of water and electrolytes, leading to diarrhea. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Protein malabsorption results from decreased mucosal uptake of amino acids and the intraluminal degradation of protein precursors by bacteria. SIBO may also be associated with a reversible form of protein-losing enteropathy. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Deficiency in vitamin B12 results from utilization of vitamin B12 coupled to intrinsic factor by anaerobic bacteria. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bacterial overgrowth can also disturb small bowel motility, causing nausea, anorexia, and bloating. (See <a class="local">'Motility and nutrient absorption'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The endoscopic appearance and histopathology of the small intestine and colon is normal in most patients with SIBO. Nonspecific changes in the small intestine and colon include mucosal edema, loss of normal vascular pattern, patchy erythema, friability, and, in rare cases, mucosal ulceration. Histopathologic changes in extreme cases associated with SIBO include villous blunting, cryptitis, intraepithelial lymphocytosis, and eosinophilia. (See <a class="local">'Morphology and histopathology'</a> above.)</p><p></p><p class="headingAnchor" id="H43216053"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Jon Vanderhoof, MD, Rosemary Pauley-Hunter, NP-C, and Mark Pimentel, MD, FRCP(C), who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Shah A, Morrison M, Holtmann GJ. Gastroduodenal "Dysbiosis": a New Clinical Entity. Curr Treat Options Gastroenterol 2018; 16:591.</a></li><li><a class="nounderline abstract_t">Gorbach SL, Plaut AG, Nahas L, et al. Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology 1967; 53:856.</a></li><li><a class="nounderline abstract_t">Walker MM, Talley NJ. Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract--beyond the era of Helicobacter pylori. Aliment Pharmacol Ther 2014; 39:767.</a></li><li><a class="nounderline abstract_t">Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008; 53:1443.</a></li><li><a class="nounderline abstract_t">Schulze J, Sonnenborn U. Yeasts in the gut: from commensals to infectious agents. Dtsch Arztebl Int 2009; 106:837.</a></li><li><a class="nounderline abstract_t">Erdogan A, Rao SS. Small intestinal fungal overgrowth. Curr Gastroenterol Rep 2015; 17:16.</a></li><li><a class="nounderline abstract_t">Phillips SF, Quigley EM, Kumar D, Kamath PS. Motility of the ileocolonic junction. Gut 1988; 29:390.</a></li><li><a class="nounderline abstract_t">Roland BC, Ciarleglio MM, Clarke JO, et al. Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO). Dig Dis Sci 2014; 59:1269.</a></li><li><a class="nounderline abstract_t">Riordan SM, McIver CJ, Wakefield D, et al. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am J Gastroenterol 2001; 96:494.</a></li><li class="breakAll">Eslick GD. Chapter 6 - Clinical Conditions Associated With Bacterial Overgrowth. In: Gastrointestinal Diseases and their Associated Infections, Elsevier, 2019. p.67.</li><li><a class="nounderline abstract_t">Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977; 59:1158.</a></li><li><a class="nounderline abstract_t">Shah ED, Basseri RJ, Chong K, Pimentel M. Abnormal breath testing in IBS: a meta-analysis. Dig Dis Sci 2010; 55:2441.</a></li><li><a class="nounderline abstract_t">Posserud I, Stotzer PO, Björnsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56:802.</a></li><li><a class="nounderline abstract_t">Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, et al. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012; 57:1321.</a></li><li><a class="nounderline abstract_t">Kim G, Morales W, Funari V, et al. Duodenal Aeromonas SPP Are Increased in Number in a Rat Model of Post-Infectious IBS: Translation of Data From Deep Sequencing of the Microbiome in Humans With IBS. Gastroenterology 2013; 144:S542.</a></li><li><a class="nounderline abstract_t">Giamarellos-Bourboulis E, Tang J, Pyleris E, et al. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scand J Gastroenterol 2015; 50:1076.</a></li><li><a class="nounderline abstract_t">Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16:2978.</a></li><li><a class="nounderline abstract_t">Jones RM, Neish AS. Recognition of bacterial pathogens and mucosal immunity. Cell Microbiol 2011; 13:670.</a></li><li><a class="nounderline abstract_t">Shah A, Talley NJ, Koloski N, et al. Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease. Aliment Pharmacol Ther 2020; 52:155.</a></li><li><a class="nounderline abstract_t">Weitsman S, Celly S, Leite G, et al. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes. Dig Dis Sci 2022; 67:224.</a></li><li><a class="nounderline abstract_t">Bushyhead D, Quigley EMM. Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management. Gastroenterology 2022; 163:593.</a></li><li><a class="nounderline abstract_t">Leite G, Rezaie A, Mathur R, et al. Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing. Clin Gastroenterol Hepatol 2023.</a></li><li><a class="nounderline abstract_t">Erdogan A, Rao SS, Gulley D, et al. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil 2015; 27:481.</a></li><li><a class="nounderline abstract_t">Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999; 94:1327.</a></li><li><a class="nounderline abstract_t">Kirsch M. Bacterial overgrowth. Am J Gastroenterol 1990; 85:231.</a></li><li><a class="nounderline abstract_t">Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol 2020; 115:165.</a></li><li><a class="nounderline abstract_t">Shindo K, Machida M, Koide K, et al. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology 1998; 45:1643.</a></li><li><a class="nounderline abstract_t">Donaldson RM Jr. Role of enteric microorganisms in malabsorption. Fed Proc 1967; 26:1426.</a></li><li><a class="nounderline abstract_t">Pai RK. A practical approach to small bowel biopsy interpretation: celiac disease and its mimics. Semin Diagn Pathol 2014; 31:124.</a></li><li><a class="nounderline abstract_t">Sherman P, Lichtman S. Small bowel bacterial overgrowth syndrome. Dig Dis 1987; 5:157.</a></li><li><a class="nounderline abstract_t">Su J, Smith MB, Rerknimitr R, Morrow D. Small intestine bacterial overgrowth presenting as protein-losing enteropathy. Dig Dis Sci 1998; 43:679.</a></li><li><a class="nounderline abstract_t">Justus PG, Fernandez A, Martin JL, et al. Altered myoelectric activity in the experimental blind loop syndrome. J Clin Invest 1983; 72:1064.</a></li><li><a class="nounderline abstract_t">Hoog CM, Lindberg G, Sjoqvist U. Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy. BMC Gastroenterol 2007; 7:29.</a></li><li><a class="nounderline abstract_t">Taylor SF, Sondheimer JM, Sokol RJ, et al. Noninfectious colitis associated with short gut syndrome in infants. J Pediatr 1991; 119:24.</a></li><li><a class="nounderline abstract_t">Klaus J, Spaniol U, Adler G, et al. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease. BMC Gastroenterol 2009; 9:61.</a></li><li><a class="nounderline abstract_t">Greenson JK. The biopsy pathology of non-coeliac enteropathy. Histopathology 2015; 66:29.</a></li><li><a class="nounderline abstract_t">Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005; 17:27.</a></li><li><a class="nounderline abstract_t">Shah A, Shanahan E, Macdonald GA, et al. Systematic Review and Meta-Analysis: Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Liver Disease. Semin Liver Dis 2017; 37:388.</a></li><li><a class="nounderline abstract_t">Maslennikov R, Pavlov C, Ivashkin V. Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis. Hepatol Int 2018; 12:567.</a></li><li><a class="nounderline abstract_t">Bongaerts GP, Tolboom JJ, Naber AH, et al. Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia. Microb Pathog 1997; 22:285.</a></li><li><a class="nounderline abstract_t">Rao SSC, Rehman A, Yu S, Andino NM. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. Clin Transl Gastroenterol 2018; 9:162.</a></li><li><a class="nounderline abstract_t">Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014; 146:1513.</a></li><li><a class="nounderline abstract_t">Lichtman SN, Keku J, Schwab JH, Sartor RB. Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun 1991; 59:555.</a></li><li><a class="nounderline abstract_t">O'Brien DP, Nelson LA, Kemp CJ, et al. Intestinal permeability and bacterial translocation are uncoupled after small bowel resection. J Pediatr Surg 2002; 37:390.</a></li><li><a class="nounderline abstract_t">Mouzaki M, Comelli EM, Arendt BM, et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 2013; 58:120.</a></li></ol></div><div id="topicVersionRevision">Topic 4783 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30421297" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Gastroduodenal "Dysbiosis": a New Clinical Entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4863722" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24612362" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract--beyond the era of Helicobacter pylori.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17990113" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : A systematic review of diagnostic tests for small intestinal bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20062581" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Yeasts in the gut: from commensals to infectious agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25786900" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Small intestinal fungal overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3281873" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Motility of the ileocolonic junction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24795035" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11232696" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11232696" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/864008" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20467896" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Abnormal breath testing in IBS: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17148502" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22262197" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Duodenal Aeromonas SPP Are Increased in Number in a Rat Model of Post-Infectious IBS: Translation of Data From Deep Sequencing of the Microbiome in Humans With IBS</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25865706" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20572300" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Small intestinal bacterial overgrowth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21352463" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Recognition of bacterial pathogens and mucosal immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32412673" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33534012" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35398346" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37315761" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25600077" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10235214" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2178395" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32023228" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9840121" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6051324" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Role of enteric microorganisms in malabsorption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24815938" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A practical approach to small bowel biopsy interpretation: celiac disease and its mimics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3311488" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Small bowel bacterial overgrowth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9539668" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Small intestine bacterial overgrowth presenting as protein-losing enteropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6350361" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Altered myoelectric activity in the experimental blind loop syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17640373" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1676730" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Noninfectious colitis associated with short gut syndrome in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19643023" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25234408" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The biopsy pathology of non-coeliac enteropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15647636" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Bacterial translocation and its consequences in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29272899" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Systematic Review and Meta-Analysis: Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Liver Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30284684" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9160298" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29915215" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24440671" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Interactions between the intestinal microbiome and liver diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1987073" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11877654" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Intestinal permeability and bacterial translocation are uncoupled after small bowel resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23401313" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Intestinal microbiota in patients with nonalcoholic fatty liver disease.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
